Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0000899243-21-035508

Chief Commercial Officer sold 5,000 shares at $37.00 ($185,000)

  • Chief Commercial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dierks Jeffrey Chief Commercial Officer 2021-09-07 Option exercise +5,000 $8.22 $41,100 5,000 D: show line 1 in the form
Dierks Jeffrey Chief Commercial Officer 2021-09-07 Sale −5,000 $37.00 $185,000 0 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $37.00 · $185,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dierks Jeffrey Chief Commercial Officer 2021-09-07 Option exercise · Stock Option −4,083 7,304 D: show line 3 in the form
Dierks Jeffrey Chief Commercial Officer 2021-09-07 Option exercise · Stock Option −917 23,428 D: show line 4 in the form
Loading xslF345X03/doc4.xml…